ebook Munafa Stock Market Course + Intraday & FNO calls  

       

AMRX announcements Amneal Pharmaceuticals, Inc. announcements and dividends declared USA

Amneal Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Amneal Pharmaceuticals, Inc. AMRX

Amneal Pharmaceuticals, Inc. AMRX listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Amneal Pharmaceuticals, Inc. AMRX

: Amneal Pharmaceuticals’ stock soars 14% premarket after company offers upbeat Q1 guidance
Amneal Pharmaceuticals Inc.’s stock AMRX soared 14% in premarket trade Monday, after the generics and specialty pharmaceuticals company offered first-quarter guidance that topped consensus estimates. Bridgewater, N.J.-based Amneal said it expects revenue
Announcement as on 17 April 2023

Amneal Pharmaceuticals (AMRX) Q3 Earnings and Revenues Lag Estimates
Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of [CO].14 per share, missing the Zacks Consensus Estimate of [CO].18 per share. This compares to earnings of [CO].21 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 04 November 2022

Amneal Pharmaceuticals (AMRX) Q3 Earnings and Revenues Lag Estimates
Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of [CO].14 per share, missing the Zacks Consensus Estimate of [CO].18 per share. This compares to earnings of [CO].21 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 04 November 2022

Amneal Pharmaceuticals (AMRX) Lags Q2 Earnings Estimates
Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of [CO].19 per share, missing the Zacks Consensus Estimate of [CO].20 per share. This compares to earnings of [CO].25 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 05 August 2022

US-based Amneal Pharmaceuticals buys India's injectable maker Punishka Healthcare for Rs 700 crores
Amneal Pharmaceuticals on Tuesday said it has acquired Ahmedabad-based injectable drug maker Puniska Healthcare Pvt. Ltd for a total value of around Rs 700 crore.
Announcement as on 09 November 2021

Announcements by Amneal Pharmaceuticals, Inc. first page | Next page | Prev page |

AMRX Amneal Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Amneal Pharmaceuticals, Inc.

  • 5Day Average: 13.02
  • 12Day Average: 12.9
  • 20Day Average: 12.71
  • 50Day Average: 12.11
  • 100Day Average: 11
  • 150Day Average: 10.08
  • 200Day Average: 9.42

AMRX Indicators & signals

Indicator MACD (12,26,9)

12.88, 12.58, 0.3
Indicator MACD is in positive zone

Indicator ADX (14)

5.88, 25.71, 22.86
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of AMRX Amneal Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Fri Jan 2026 12.96 12.93 to 13.31 -1.82% 1.21 times
08 Thu Jan 2026 13.20 13.19 to 13.48 -0.45% 0.98 times
07 Wed Jan 2026 13.26 13.15 to 13.37 2.08% 1.21 times
06 Tue Jan 2026 12.99 12.77 to 13.25 2.2% 1.2 times
05 Mon Jan 2026 12.71 12.33 to 12.83 0.39% 1.38 times
02 Fri Jan 2026 12.66 12.38 to 12.79 0.48% 0.97 times
31 Wed Dec 2025 12.60 12.59 to 12.91 -2.17% 1.31 times
30 Tue Dec 2025 12.88 12.86 to 12.99 -0.31% 0.96 times
29 Mon Dec 2025 12.92 12.75 to 13.15 -0.23% 0.55 times
26 Fri Dec 2025 12.95 12.82 to 13.01 0.62% 0.78 times
24 Wed Dec 2025 12.87 12.75 to 12.98 0.23% 0.65 times
23 Tue Dec 2025 12.84 12.78 to 12.97 0.16% 1.78 times

Videos related to: AMRX announcements Amneal Pharmaceuticals, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

AMRX announcements Amneal Pharmaceuticals, Inc. announcements and dividends declared USA

 

Back to top